07/16/2025
6:02 PM | BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
| Form SCHEDULE 13G/A | |
07/16/2025
8:32 AM | Urogen Pharma (Filer)
| Form ARS | |
07/15/2025
3:56 PM | Urogen Pharma (Filer)
| Form DEF 14A | |
07/03/2025
3:16 PM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
10:38 AM | Cowen Financial Products LLC (Filed by)
Urogen Pharma (Subject)
| Form SCHEDULE 13G | |
06/13/2025
7:00 AM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
8:14 AM | Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
8:27 AM | Schoenberg Mark (Reporting)
Urogen Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2025
6:19 PM | Monograph Capital Holdings Advisors, LLC (Filed by)
Urogen Pharma (Subject)
| Form SCHEDULE 13D/A | |
05/12/2025
8:02 AM | Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025
7:06 AM | Urogen Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for URGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Urogen Pharma and its competitors with MarketBeat's FREE daily newsletter. |
05/12/2025
7:03 AM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
12:23 PM | MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
| Form SCHEDULE 13G/A | |
03/10/2025
3:32 PM | Urogen Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/10/2025
7:02 AM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
7:05 AM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
8:34 AM | Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
9:09 AM | MORGAN STANLEY (Filed by)
Urogen Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/04/2025
10:49 AM | Barrett Elizabeth A. (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
10:51 AM | Smith Jason Drew (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
10:53 AM | Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
6:01 AM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
5:16 AM | Pontifax Management III G.P. Ltd. (0001726335) (Filed by)
Urogen Pharma (Subject)
| Form SC 13D/A | |
11/14/2024
6:46 PM | Point72 Asset Management, L.P. (Filed by)
Urogen Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Urogen Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
11:04 AM | MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
7:37 AM | COWEN AND COMPANY, LLC (Filed by)
Urogen Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
5:44 AM | RTW INVESTMENTS, LP (Filed by)
Urogen Pharma (Subject)
| Form SC 13G/A | |
11/12/2024
8:30 AM | Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
| Form SC 13G | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
| Form SC 13G | |
11/06/2024
12:50 PM | MORGAN STANLEY (Filed by)
Urogen Pharma (Subject)
| Form SC 13G | |
11/06/2024
7:01 AM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
7:04 AM | Urogen Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
| Form SC 13G | |
10/09/2024
3:21 PM | Degnan Chris (Reporting)
Urogen Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/09/2024
3:22 PM | Degnan Chris (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
7:18 AM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
3:15 PM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
12:51 PM | Smith Jason Drew (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
12:54 PM | Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
12:50 PM | Kim Dong (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
5 Stocks Poised to Soar Under Trump's Presidency (Ad) With the next presidential cycle heating up and Trump leading the charge, major market shifts are already taking shape.
For investors who position early, the opportunities could be significant.
That’s why we’ve just released a brand-new report:
📈 “5 Best Stocks to Buy Under Trump’s Presidency.” Get the full report here—and stay ahead of the curve. |
09/10/2024
6:16 AM | Schoenberg Mark (Reporting)
Urogen Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
7:00 AM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:01 AM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:05 AM | Urogen Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
3:30 PM | Urogen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
8:06 AM | BUTITTA CYNTHIA M (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:07 AM | Urogen Pharma (Issuer)
WEN LEANA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:08 AM | Robinson James A. Jr. (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:09 AM | Holden Stuart (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:10 AM | Urogen Pharma (Issuer)
Wildman Daniel George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:11 AM | Cohen Fred E (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:11 AM | Belldegrun Arie (Reporting)
Urogen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
